α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells

Peng, Xiangmin M., Tehranian, Roya, Dietrich, Paula, Stefanis, Leonidas, Perez, Ruth G.·2005·Journal of Cell Science

DOI 10.1242/jcs.02481

Cited by (250)

Items 101–200 of 250

Lithium Improves Dopamine Neurotransmission and Increases Dopaminergic Protein Abundance in the Striatum after Traumatic Brain Injury
Shaun W. Carlson, C. Dixon · 2018 · Journal of Neurotrauma
In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies
Amir Tayaranian Marvian, David J. Koss, Farhang Aliakbari, Dina Morshedi, Tiago F. Outeiro · 2019 · Journal of Neurochemistry
A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson’s disease: Emerging concepts and challenges
Velmarini Vasquez, Joy Mitra, Haibo Wang, Pavana M. Hegde, K. S. Jagannatha Rao, Muralidhar L. Hegde · 2019 · Progress in Neurobiology
Novel FTY720-Based Compounds Stimulate Neurotrophin Expression and Phosphatase Activity in Dopaminergic Cells
Javier Vargas‐Medrano, Sesha Krishnamachari, Ernesto Villanueva, Wesley H. Godfrey, Haiyan Lou, Chinnasamy Ramesh, Jeffrey B. Arterburn, Ruth G. Perez · 2014 · ACS Medicinal Chemistry Letters
PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability
Christina Fevga, Christelle Tesson, Ana Carreras Mascaro, Thomas Courtin, Riaan van Coller, Salma Sakka, Federico Ferraro, Nouha Farhat, Soraya Bardien, Mariem Damak et al. · 2022 · Brain
Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function
Kerstin Buck, Natalie Landeck, Ayşe Ulusoy, Nour K. Majbour, Omar M. A. El‐Agnaf, Deniz Kirik · 2015 · Neurobiology of Disease
The ALDH2 and DRD2/ANKK1 genes interacted in bipolar II but not bipolar I disorder
Sheng-Yu Lee, Shiou‐Lan Chen, Yun‐Hsuan Chang, Shih‐Heng Chen, Chun-Hsieh Chu, San‐Yuan Huang, Nian‐Sheng Tzeng, Chen‐Lin Wang, I Hui Lee, Tzung Lieh Yeh et al. · 2010 · Pharmacogenetics and Genomics
An Endogenous Serine/Threonine Protein Phosphatase Inhibitor, G-Substrate, Reduces Vulnerability in Models of Parkinson's Disease
Chee Yeun Chung, James B. Koprich, Shogo Endo, Ole Isacson A · 2007 · Journal of Neuroscience
Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats
Elżbieta Lorenc‐Koci, Tomasz Lenda, Lucyna Antkiewicz‐Michaluk, Jadwiga Wardas, Helena Domin, Maria Śmiałowska, Jolanta Konieczny · 2011 · Neurochemistry International
The Clathrin-Dependent Localization of Dopamine Transporter to Surface Membranes Is Affected by α-Synuclein
Haya Kisos, Tziona Ben‐Gedalya, Ronit Sharon · 2013 · Journal of Molecular Neuroscience
Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions
Jean‐Luc Dreyer · 2010 · Molecular Biotechnology
Linking Alpha-Synuclein to the Actin Cytoskeleton: Consequences to Neuronal Function
Marina I. Oliveira da Silva, Márcia A. Liz · 2020 · Frontiers in Cell and Developmental Biology
An updated review on animal models to study attention-deficit hyperactivity disorder
Daegeon Kim, Dhananjay Yadav, Minseok Song · 2024 · Translational Psychiatry
Effect of ginsenoside Rg3 on tyrosine hydroxylase and related mechanisms in the forced swimming-induced fatigue rats
Yuxia Xu, Peng Zhang, Chu Wang, Shan Ye, Dandan Wang, Fenglei Qian, Mengwei Sun, Cuiqing Zhu · 2013 · Journal of Ethnopharmacology
Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson’s Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein Expression
Anderson H.F.F. Leão, Ywlliane da Silva Rodrigues Meurer, Anatildes F. Silva, André M. Medeiros, Clarissa Loureiro das Chagas Campêlo, Vanessa Costhek Abílio, Rovena Clara Galvão Januário Engelberth, Jeferson S. Cavalcante, Geison Souza Izídio, Alessandra Mussi Ribeiro et al. · 2017 · Frontiers in Aging Neuroscience
Neuroprotective effect of YIAEDAER peptide against Parkinson’s disease like pathology in zebrafish
Qingyu Ren, Xin Jian Jiang, Shanshan Zhang, Xin Gao, Yam Nath Paudel, Pengyu Zhang, Rongchun Wang, Kechun Liu, Meng Jin · 2022 · Biomedicine & Pharmacotherapy
Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson’s disease
Steven P. Braithwaite, Michael V. Voronkov, Jeffry B. Stock, M. Maral Mouradian · 2012 · Neurochemistry International
Lymphocyte Proteomics of Parkinson‘s Disease Patients Reveals Cytoskeletal Protein Dysregulation and Oxidative Stress
Silvia Mila, Alessandra Giuliano Albo, Davide Corpillo, Sabrina Giraudo, Maurizio Zibetti, Enrico M Bucci, Leonardo Lopiano, Mauro Fasano · 2009 · Biomarkers in Medicine
Mitochondrial dysfunction in mouse models of Parkinson’s disease revealed by transcriptomics and proteomics
Desmond Smith · 2009 · Journal of Bioenergetics and Biomembranes
Neuronal hemoglobin in mitochondria is reduced by forming a complex with α-synuclein in aging monkey brains
Weiwei Yang, Xuran Li, Xin Li, Xuying Li, Shun Yu · 2016 · Oncotarget
Early-onset parkinsonism in PPP2R5D-related neurodevelopmental disorder
Katalin L.M.L. Hetzelt, Frank Kerling, Cornelia S. Kraus, Christophe Rauch, Christian Thomas Thiel, Martin Winterholler, André Reis, Christiane Zweier · 2020 · European Journal of Medical Genetics
DOPAnization of tyrosine in α-synuclein by tyrosine hydroxylase leads to the formation of oligomers
Mingyue Jin, Sakiko Matsumoto, Takashi Ayaki, Hodaka Yamakado, Tomoyuki Taguchi, Natsuko Togawa, Ayumu Konno, Hirokazu Hirai, Hiroshi Nakajima, Shoji Komai et al. · 2022 · Nature Communications
Molecular and Neurochemical Mechanisms in PD Pathogenesis
Irmgard B. Paris, Jorge Lozano, Carolina Perez-Pastene, Patricia Muñoz, Juan Segura‐Aguilar · 2009 · Neurotoxicity Research
Interplay of α-Synuclein Oligomers and Endoplasmic Reticulum Stress in Parkinson'S Disease: Insights into Cellular Dysfunctions
Hui Zeng, Ye Liu, Xinjie Liu, Jianwei Li, Lixuan Lu, Xue Cheng, Xiao Wu, Xinran Zhang, Zijian Zheng, Guohui Lu · 2024 · Inflammation
Ellagic Acid Prevents α-Synuclein Aggregation and Protects SH-SY5Y Cells from Aggregated α-Synuclein-Induced Toxicity via Suppression of Apoptosis and Activation of Autophagy
Mustafa Taleb Ardah, Nabil A. S. Eid, Tohru Kitada, M. Emdadul Haque · 2021 · International Journal of Molecular Sciences
Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules
Ana Jorge‐Finnigan, Rune Kleppe, Kunwar Jung‐KC, Ming Ying, Michaël Marie, Iván Ríos-Mondragón, Michael F. Salvatore, Jaakko Saraste, Aurora Martı́nez · 2017 · Journal of Biological Chemistry
PC12 Cells as a model for parkinson's disease research
Cristina Malagelada, Lloyd A. Greene · 2008 · Elsevier eBooks
Identification by nano-LC-MS/MS of NT5DC2 as a protein binding to tyrosine hydroxylase: Down-regulation of NT5DC2 by siRNA increases catecholamine synthesis in PC12D cells
Akira Nakashima, Hisateru Yamaguchi, Yu Kodani, Yoko S. Kaneko, Miho Kawata, Hiroshi Nagasaki, Toshiharu Nagatsu, Akira Ota · 2019 · Biochemical and Biophysical Research Communications
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka, Maria Xilouri · 2020 · Frontiers in Cell and Developmental Biology
Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models
Xiu-Qi Bao, Xiangchen Kong, Li-Bing Kong, Liang-Yu Wu, Hua Sun, Dan Zhang · 2014 · Brain Research
FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models
Guadalupe Vidal-Martínez, Ismael Segura‐Ulate, Barbara Carolyn Yang, Valeria Diaz-Pacheco, Jose A. Barragan, Jocelyn De-Leon Esquivel, Stephanie A. Chaparro, Javier Vargas‐Medrano, Ruth G. Perez · 2019 · Experimental Neurology
Subthalamic nucleus deep brain stimulation protects neurons by activating autophagy via PP2A inactivation in a rat model of Parkinson's disease
Tingting Du, Ying‐Chuan Chen, Yongquan Lu, Fangang Meng, Hui Yang, Jian‐Guo Zhang · 2018 · Experimental Neurology
Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson’s Like Symptoms Without Loss of Dopaminergic Neurons
Monika Sharma, Jaswinder Kaur, Siddhi Rakshe, Nishant Sharma, Dignesh Khunt, Amit Khairnar · 2021 · Neurotoxicity Research
Parkinsonism in Genetic Neurodevelopmental Disorders: A Systematic Review
Emma vonScheibler, A. V. van Eeghen, T. D. de Koning, M. Kuijf, J. Zinkstok, Annelieke R. Müller, T. van Amelsvoort, E. Boot · 2022 · Movement Disorders Clinical Practice
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Maria Mancini, Silvia Natoli, Fabrizio Gardoni, Mónica Di Luca, Antonio Pisani · 2023 · International Journal of Molecular Sciences
Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay
Charlotte Welinder, Goran B Jönsson, Christian Ingvar, Lotta Lundgren, Bo Baldetorp, Hakan Lars Olsson, Thomas Breslin, Melinda Rezeli, Bo Jansson, Thomas E. Fehniger et al. · 2014 · PLoS ONE
The Role of α-Synuclein in Methamphetamine-Induced Neurotoxicity
Manqing Wu, Hang Su, Min Zhao · 2021 · Neurotoxicity Research
Interplay between α-synuclein and parkin genes: Insights of Parkinson’s disease
Kajal Sharma, Shivani Chib, Aniket Gupta, Randhir Singh, Rishabh Chalotra · 2024 · Molecular Biology Reports
The SUMO Conjugase Ubc9 Protects Dopaminergic Cells from Cytotoxicity and Enhances the Stability of α-Synuclein in Parkinson’s Disease Models
Dinesh Verma, Anurupa Ghosh, Lindsey Ruggiero, Etienne A. Cartier, Eric M. Janezic, Dionne Williams, Eui‐Gil Jung, Michael Moore, Jong Bok Seo, Yong‐Hwan Kim · 2020 · eNeuro
Neuronal Bmi-1 is critical for melatonin induced ubiquitination and proteasomal degradation of α-synuclein in experimental Parkinson's disease models
Anup Kumar Srivastava, Subhasree Roy Choudhury, Surajit Karmakar · 2020 · Neuropharmacology
Developmental exposure to the Parkinson’s disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice
S. Boyd, Nathan C. Kuhn, Joseph R. Patterson, Anna C. Stoll, Sydney A Zimmerman, Mason R. Kolanowski, Joseph J. Neubecker, Kelvin C. Luk, Eric S. Ramsson, Caryl E. Sortwell et al. · 2023 · Toxicological Sciences
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson’s disease
Makoto Naoi, Wakako Maruyama, Masayo Shamoto‐Nagai, Peter Franz Riederer · 2024 · Journal of Neural Transmission
Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy
K. Kawahata, Kohji Fukunaga · 2021 · Journal of Pharmacological Sciences
Interference of alpha-synuclein with cAMP/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells
Sa Suk Kim, Kyung Rok Moon, Hyun Jin Choi · 2011 · Archives of Pharmacal Research
The role of α-synuclein in neurodegeneration — An update
K. A. Jellinger · 2012 · Translational Neuroscience
Protein Phosphatase 2A is Involved in the Tyrosine Hydroxylase Phosphorylation Regulated by α-Synuclein
Hua Gao, Xiaolei Lan, Yang Weiwei, Hao Wang, Yuangang Zhu, Liu Dongmei, Zhang Yazhuo, Yang Hui · 2015 · Neurochemical Research
Towards New Therapies for Parkinson's Disease
David Isaac Finkelstein · 2011 · InTech eBooks
Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils
Joseph R. Patterson, Joseph J. Kochmanski, Anna C. Stoll, Michael Kubik, Christopher J. Kemp, Megan F. Duffy, Kaje’ne E. Thompson, Jacob W. Howe, Allyson Cole-Strauss, Nathan C. Kuhn et al. · 2024 · npj Parkinson s Disease
Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions
Jean‐Luc Dreyer · 2009 · Methods in molecular biology
Intranasal Carnosine Mitigates α-Synuclein Pathology and Motor Dysfunction in the Thy1-aSyn Mouse Model of Parkinson’s Disease
Josephine M. Brown-Leung, Lauren S. Baker, Kim B. Seroogy, Mary Beth Genter · 2021 · ACS Chemical Neuroscience
Leucine Carboxyl Methyltransferase Downregulation and Protein Phosphatase Methylesterase Upregulation Contribute Toward the Inhibition of Protein Phosphatase 2A by α-Synuclein
Hao Ming Tian, Yongquan Lu, Jia Liu, Weijin Liu, Lingling Lu, Chunli Duan, Ge Gao, Hui Yang · 2018 · Frontiers in Aging Neuroscience
The Role of Alpha-Synuclein Deposits in Parkinson’s Disease: A Focus on the Human Retina
Mariachiara Di Pippo, Serena Fragiotta, Federico Di Staso, Luca Scuderi, Solmaz Abdolrahimzadeh · 2023 · International Journal of Molecular Sciences
Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway
Sasuk Kim, Juhee Lim, Yeojin Bang, Jisook Moon, Min‐Soo Kwon, Jin Tae Hong, Jeha Jeon, Hyemyung Seo, Hyun Jin Choi · 2017 · Molecular Neurobiology
A Brief Overview of Tyrosine Hydroxylase and α-Synuclein in the Parkinsonian Brain
Wajihullah Khan, Medha Priyadarshini, Haytham Ahmed Zakai, Mohammad Amjad Kamal, Qamre Alam · 2012 · CNS & Neurological Disorders - Drug Targets
The Quinpirole Hypolocomotive Effects are Strain and Route of Administration Dependent in SHR and SLA16 Isogenic Rats
Renata Aparecida Nedel Pértile, María Elisa Corvino, Renata C.N. Marchette, Eloísa Pavesi, Juliana Cavalli, André Ramos, Geison Souza Izídio · 2017 · Behavior Genetics
Short-term regulation of tyrosine hydroxylase activity and expression by endothelin-1 and endothelin-3 in the rat posterior hypothalamus
Guadalupe Perfume, Carolina Morgazo, Sabrina L. Nabhen, Agustina Batistone, Sandra Ingrid Hope, Liliana Graciela Bianciotti, Marcelo Sergio Vatta · 2007 · Regulatory Peptides
Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson’s Disease and Diabetes as Well as Potential Therapies?
Guadalupe Vidal-Martínez, Barbara Carolyn Yang, Javier Vargas‐Medrano, Ruth G. Perez · 2018 · Frontiers in Molecular Neuroscience
Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease
Gioia Marino, Paolo Calabresi, Veronica Ghiglieri · 2022 · Handbook of clinical neurology
Small molecule-based fluorescent probes for the detection of α-Synuclein aggregation states
Rajibul Haque, Debabrata Maity · 2023 · Bioorganic & Medicinal Chemistry Letters
The interaction between calcineurin and α-synuclein is regulated by calcium and calmodulin
Xiaoyu Shi, Yue Ran Sun, Ping Wang, Lingling Gu, Lu Wang, Huan Yang, Qun Wei, Zhimei Li, Jing Luo · 2018 · Biochemical and Biophysical Research Communications
Melatonin attenuates the amphetamine-induced decrease in vesicular monoamine transporter-2 expression in postnatal rat striatum
Sujira Mukda, Oranich Vimolratana, Piyarat Govitrapong · 2010 · Neuroscience Letters
Effect of amyloids on the vesicular machinery: implications for somatic neurotransmission
Anand Kant Das, Rucha Pandit, Sudipta Maiti · 2015 · Philosophical Transactions of the Royal Society B Biological Sciences
Development of an enzyme-linked immunosorbent assay (ELISA) to measure the level of tyrosine hydroxylase protein in brain tissue from Parkinson's disease models
Donald Fauss, Ruth N. Motter, Lilibeth Dofiles, Maria Armanda Viana Rodrigues, Monica You, Linnea Diep, Yangli Yang, Pui Seto, Kevin Tanaka, Jeanne Baker et al. · 2013 · Journal of Neuroscience Methods
Deciphering the New Role of the Greatwall/PP2A Pathway in Cell Cycle Control
Thierry Lorca, Anna Castro · 2012 · Genes & Cancer
Alpha-synuclein overexpression induces epigenomic dysregulation of glutamate signaling and locomotor pathways
Samantha L. Schaffner, Zinah Wassouf, Diana F. Lázaro, Mary Xylaki, Nicole Gladish, David T S Lin, Julia L. MacIsaac, Katia E. Ramadori, Thomas Hentrich, Julia Maria Schulze-Hentrich et al. · 2022 · Human Molecular Genetics
PINK1 suppresses alpha-synuclein-induced neuronal injury: a novel mechanism in protein phosphatase 2A activation
Weiwei Yang, Xue Wang, Jia Liu, Chunli Duan, Ge Gao, Lingling Lu, Shun Yu, Hui Yang · 2017 · Oncotarget
“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
Bipul Ray, Arehally Marappa Mahalakshmi, Sunanda Tuladhar, Abid Bhat, Asha Srinivasan, Christophe Pellegrino, Anbarasu Kannan, Srinivasa Rao Bolla, Saravana Babu Chidambaram, Meena Kishore Sakharkar · 2021 · Frontiers in Cell and Developmental Biology
Sphingosine‐1‐phosphate receptor‐independent lung endothelial cell barrier disruption induced by FTY720 regioisomers
Sara M. Camp, Alexander Marciniak, Eddie T. Chiang, Alexander Nathaniel Garcia, Robert Bittman, Robin L. Polt, Ruth G. Perez, Steven M. Dudek, Joe G. N. Garcia · 2020 · Pulmonary Circulation
Regulation of tyrosine hydroxylase: relevance to Parkinson's disease
Gelareh Alam, Jason R. Richardson · 2020 · Elsevier eBooks
Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson’s Disease-Associated Pathology
Jun Sung Park, Riaz Ahmad, Kyonghwan Choe, Min Hwa Kang, Tae Ju Park, Myeong Ok Kim · 2023 · Vaccines
Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy
Julius O. Enoru, Barbara Carolyn Yang, Sesha Krishnamachari, Ernesto Villanueva, William DeMaio, Adiba Watanyar, Chinnasamy Ramesh, Jeffrey B. Arterburn, Ruth G. Perez · 2016 · PLoS ONE
Rare Missense Variants in The Ppp2r5dgene Associated with Parkinson's Disease in the Han Chinese Population
Pingping Ning, Kelu Li, Hui Jun Ren, Hongju Yang, Yanming Xu, Xinglong Yang · 2021 · Neuroscience Letters
Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI
Xing'an Li, Yingjiu Zhang, Peng Xie, Jinhua Piao, Yihong Hu, Ming Chang, Tao Liu, Linsen Hu · 2010 · BMC Neuroscience
NT5DC2 affects the phosphorylation of tyrosine hydroxylase regulating its catalytic activity
Akira Nakashima, Hisateru Yamaguchi, Mii Kondo, Takahiro Furumura, Yu Kodani, Yoko S. Kaneko, Miho Kawata, Hiroshi Nagasaki, Toshiharu Nagatsu, Akira Ota · 2020 · Journal of Neural Transmission
From innate to adaptive immunity: Abomasal transcriptomic responses of merino sheep to Haemonchus contortus infection
Jing Liu, Min Jie Alvin Tan, Xiangdong Xu, Tingbo Shen, Zihao Zhou, Peter William Hunt, Runfeng Zhang · 2021 · Molecular and Biochemical Parasitology
Parkinson’s Disease and Its Dermatological Associations: Is Your Skin Whispering You a Diagnosis?
Puja Shah, Prem Raj Sagar, Norah Alhumaidi, Vijaya Chaitanya Bollampally, Bilal Haider Malik · 2020 · Cureus
Lippia grata essential oil complexed with β-cyclodextrin ameliorates biochemical and behavioral deficits in an animal model of progressive parkinsonism
José Ivo Araújo Beserra‐Filho, Amanda Maria‐Macêdo, Suellen Silva‐Martins, Ana Cláudia Custódio‐Silva, Beatriz Soares‐Silva, Sara Pereira Silva, Rafael Herling Lambertucci, Adriano Antunes de Souza Araújo, María Angélica, Lucindo José Quintans‐Júnior et al. · 2022 · Metabolic Brain Disease
Regulation of α‐synuclein expression in down syndrome
Narayan Ramakrishna, Harry C. Meeker, Satyam Patel, Ted W. Brown, Abdeslem El Idrissi · 2012 · Journal of Neuroscience Research
Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia
Ashish Kumar Gupta, Ruchika Pokhriyal, Uddipan Das, Mohd Imran Khan, Domada Ratna Kumar, Rishab Gupta, Rakesh Kumar Chadda, Rashmi Ramachandran, Vinay Goyal, Manjari Tripathi et al. · 2019 · Neuropsychiatric Disease and Treatment
Genetics of Parkinson's Disease
Yue Ming Huang, Piu Chan, Glenda Margaret Halliday · 2007 · Elsevier eBooks
Parkinson's Disease: What Can Retinal Imaging Tell Us?
Mariachiara Di Pippo, Sergio d’Agostino, Francesco Ruggeri, Chiara Carrozzi, Davide Fasciolo, Solmaz Abdolrahimzadeh · 2024 · Journal of Integrative Neuroscience
Prion Efficiently Replicates in α-Synuclein Knockout Mice
Edoardo Bistaffa, Martina Rossi, Chiara Maria Giulia De Luca, Federico Angelo Cazzaniga, Olga Carletta, Ilaria Campagnani, Fabrizio Tagliavini, Giuseppe Legname, Giorgio Giaccone, Fabio Moda · 2019 · Molecular Neurobiology
Does a hypoxic injury from a non-fatal overdose lead to an Alzheimer Disease?
Michael V. Voronkov, Benjamin F. Cocchiaro, Jeffry B. Stock · 2020 · Neurochemistry International
Does sympathetic dysfunction occur before denervation in pure autonomic failure?
Ling Guo, Murray Esler, Carolina Ika Sari, Sarah E. Phillips, Élisabeth Lambert, Nora E. Straznicky, Gavin William Lambert, Susan J. Corcoran · 2017 · Clinical Science
Alpha Synuclein and Parkinson’s Disease
Arti Parihar, Priyanka Parihar, Isha Solanki, Mordhwaj Singh Parihar · 2018 · Springer eBooks
The influence of chromosome 4 on metabolism and spatial memory in SHR and SLA16 rat strains
Ana Magdalena Velázquez, Katiane Roversi, Patrícia Dillenburg-Pilla, Rodrigo Ferracine Rodrigues, Carlos R. Zárate-Bladés, Rui Daniel Prediger, Geison Souza Izídio · 2019 · Behavioural Brain Research
Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
Sovanarak Lek, Javier Vargas‐Medrano, Ernesto Villanueva, Brian S. Marcus, Wesley H. Godfrey, Ruth G. Perez · 2017 · Journal of Visualized Experiments
Neurodegenerative dementia and Parkinsonism
Audrey Gabelle, Florence Portet, Claudine Berr, Jacques Touchon · 2010 · The journal of nutrition health & aging
Role of NT5DC2 in tyrosine hydroxylase phosphorylation based on the analysis of NT5DC2-binding proteins
Hisateru Yamaguchi, Satoshi Hara, Hiroshi Ichinose, Hiroshi Nagasaki, Akira Nakashima · 2024 · Biochemical and Biophysical Research Communications
Alpha-synuclein (SNCA) polymorphisms exert protective effects on memory after mild traumatic brain injury
Kevin Shee, Alexandra T. Lucas, Laura A. Flashman, Kwangsik T. Nho, Gregory J. Tsongalis, Brenna C. McDonald, Andrew J. Saykin, Thomas W. McAllister, C. Harker Rhodes · 2016 · Neuroscience Letters
Reduced TH expression and α-synuclein accumulation contribute towards nigrostriatal dysfunction in experimental hepatic encephalopathy
Isabel Suárez, Guillermo Bodega, Miguel Rubio, Benjamı́n Fernández · 2017 · Restorative Neurology and Neuroscience
Novel 4-triazole phenyl amide (4-TPA) molecules: Potent promoters of α-synuclein fibril disassembly
Chenyang Qiu, Ruonan Wei, Jiang Bian, Xin Lin, Tengfei Bai, Jie He, Xiaomin Guo, Yong Chu · 2024 · European Journal of Medicinal Chemistry
The Role of the Ganglion Cell Layer as an OCT Biomarker in Neurodegenerative Diseases
Francesco Ruggeri, Daniele Fumi, Lorena Bassis, Mariachiara Di Pippo, Solmaz Abdolrahimzadeh · 2025 · Journal of Integrative Neuroscience
Insights into aggregation dynamics of NACore peptides from coarse‐grained simulations
Rui‐jing Huang, Ran Tang, Song Xiang-yan, Jing‐han Wang, Kang Chen, Wen‐de Tian · 2022 · Proteins Structure Function and Bioinformatics
Parkinson's disease models: From toxins to genes
Marie‐Françoise Chesselet, Pierre‐Olivier Fernagut, Sheila M. Fleming · 2005 · Drug Discovery Today Disease Models
Brain Region-Specific Expression Levels of Synuclein Genes in an Acid Sphingomyelinase Knockout Mouse Model: Correlation with Depression-/Anxiety-Like Behavior and Locomotor Activity in the Absence of Genotypic Variation
Razvan-Marius Brazdis, Iulia Zoicas, Johannes Kornhuber, Christiane Mühle · 2024 · International Journal of Molecular Sciences
Serum alpha-synuclein in restless legs syndrome
Aboud Tahanis, Vera I. Hashem, William G. Ondo · 2024 · SLEEP
Revisiting the advance of age-dependent α-synuclein propagation and aggregation
Dong‐Yan Song, Jiayi Li · 2025 · Ageing and Neurodegenerative Diseases
Targeting Tyrosine Hydroxylase to Improve Bradykinesia
Michael F. · 2012 · InTech eBooks
A Novel Prion Protein-Tyrosine Hydroxylase Interaction
Mattia Vicario, Adriana Zagari, Vincenzo Granata, Francesca Munari, Stefano Mammi, Luigi Bubacco, Stephen D. Skaper, Alessandro Negro · 2014 · CNS & Neurological Disorders - Drug Targets